Continuous Glucose Monitoring (CGM) in an Underserved Population

🩺 Protocol Summary

The investigators aim is to conduct a randomized clinical trial in an underserved population who are either uninsured or on Medicaid and taking at least one injection of insulin daily. The investigators believe that this study will lead to considerable alleviation of health disparities and provide better care for an underserved population. This will be a pilot study to evaluate the feasibility of such a trial in this population before doing a larger multicenter trial.

Primary Research Facility: University Medical Center (New Orleans, Louisiana)

Review these 3 basic logistical and protocol criteria extracted from the public NIH record. (This is a preliminary logistical checklist, not an official clinical eligibility determination).

Diagnosed with, undergoing evaluation for, or seeking treatment related to Diabetes?

🔍 Study Population / Focus Area (Source: Protocol Primary Condition)

Aged between 18 Years and 75 Years?

🔍 Protocol Specified Age Range: 18 Years to 75 Years

Able to attend required clinic visits at University Medical Center (New Orleans, Louisiana)?

🔍 Logistical Requirement: Site at University Medical Center

📍 Primary Site Map

Site: University Medical Center — New Orleans, Louisiana

💰 Clinical Trial Costs & Insurance Coverage

Coverage for clinical trial participation varies depending on your health insurance policy, state legislation, and whether specific procedures are investigational research or routine medical care. Under federal law (Affordable Care Act § 2709), health insurers generally cannot drop coverage or refuse to pay for routine patient care costs incurred in approved clinical trials.

💡 Always ask the study coordinator for the trial's official Informed Consent Form, which outlines all sponsor-funded research items versus procedures billed to your insurance.